Randomised Controlled Trial to Assess Whether Computed Tomography Cardiac Angiography Can Improve Invasive Coronary Angiography in Bypass Surgery Patients — BYPASS-CTCA

Contrast-induced Nephropathy Clinical Trial

Official title:
A Randomised Controlled Trial Assessing the Value of Computed Tomography Cardiac Angiography in Improving Patient Satisfaction and Reducing Contrast Load, Procedural Duration and Complications in Patients Who Had Previous Bypass Operation Undergoing Invasive Coronary Angiography

Status Active, not recruiting

Clinical Trial Summary

A large number of patients with symptomatic ischaemic heart disease undergo coronary artery bypass grafting (CABG) to alleviate their symptoms and improve prognosis. Given the progressive nature of coronary disease, bypass grafts can narrow or block over time, leading to chest pain and the need for further invasive coronary angiography. Invasive coronary procedures in patients with bypass grafts can be more complicated due to the variation in bypass graft ostia. This can lead to longer procedure times, with higher doses of contrast and radiation and more discomfort for the patient. The aim of this study is to see if the use of computed tomography cardiac angiography (CTCA) in patients with previous bypass grafts prior to invasive coronary angiography will help make their procedure safer and quicker.

Clinical Trial Description

The BYPASS-CTCA trial is a single-centre, randomised controlled trial, which plans to recruit 688 patients who have had previous bypass grafts and require invasive coronary angiography over a period of 30 months. Patients will be randomised to receive either computed tomography cardiac angiography (CTCA) prior to their invasive coronary angiogram, or invasive coronary angiography alone. The primary endpoints will be the incidence of contrast induced nephropathy, the duration of the invasive coronary angiographic procedure and patient satisfaction. A number of secondary endpoints will also be looked at. Findings from BYPASS-CTCA will potentially demonstrate that a CTCA prior to invasive coronary angiography in this cohort of patients reduces the incidence of contrast-induced kidney injury, the length of procedure and improves patients satisfaction. The results of this trial may influence future clinical practice guidelines in coronary artery bypass graft patients undergoing invasive coronary procedures. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03736018
Study type	Interventional
Source	Queen Mary University of London
Contact
Status	Active, not recruiting
Phase	N/A
Start date	November 15, 2018
Completion date	September 30, 2023

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT04877847` - Multi-Center Trial Utilizing Low Frequency Ultrasound in the Prevention of Post-Contrast Acute Kidney Injury	N/A
Recruiting	`NCT02088502` - Theophylline, N-acetylcysteine, and Theophylline Plus N-acetylcysteine in Preventing Contrast-induced Nephropathy	Phase 2/Phase 3
Completed	`NCT03329443` - The Effect of Spironolactone on Acute Kidney Injury in Patients Undergoing Coronary Angiography	Phase 2
Recruiting	`NCT04864847` - Clinical Validation of the RENISCHEM L-FABP POC Assay
Completed	`NCT03627130` - The Use of Inorganic Nitrate for the Prevention of Contrast-induced Nephropathy	Phase 2
Withdrawn	`NCT04598516` - Maastricht Investigation of Renal Function in Absence of- and Post- Contrast in Patients With eGFR LEss Than 30
Withdrawn	`NCT04603261` - Time to Excretion of Contrast, a Maastricht Prospective Observational Study
Recruiting	`NCT03755700` - Vitamin E and N-acetylcysteine for Preventing Contrast-Induced Acute Kidney Injury After Coronary Artery Catheterization	Phase 3
Active, not recruiting	`NCT04606056` - Risk of Acute Kidney Injury After Intravenous Contrast Computed Tomography Scans
Terminated	`NCT02440646` - Natural History of Coronary Atherosclerosis in Real-World Stable Chest Pain Patients Underwent Computed Tomography Angiography in Comparison With Invasive Multimodality Imaging
Completed	`NCT00175227` - Prevention of Contrast-Induced Nephropathy	N/A
Completed	`NCT04014153` - CI-AKI in Patients With Stable CAD and Comorbidities. Are we Doing Better?
Withdrawn	`NCT04597892` - Efficacy of Point-Of-Care Creatinine Assays in Patients With eGFR <30 Receiving Intravascular Contrast
Completed	`NCT03305874` - Automated Prediction and Prevention of Contrast Induced Nephropathy After Cardiac Catheterization
Not yet recruiting	`NCT01871792` - Preventive Effect of Pitavastatin on Contrast-Induced Nephropathy in Patients With Renal Dysfunction	Phase 4
Recruiting	`NCT05271448` - Continuing or Discontinuing ACE/ARBs in Patients With Chronic Kidney Disease Undergoing Coronary Angiography	N/A
Withdrawn	`NCT03806725` - Safety of Iodinated Contrast in Liver Transplant Candidates With Decreased Renal Function Undergoing Coronary CT Angiography
Completed	`NCT04163250` - Use of Urinary Cell-Cycle Arrest Biomarkers in Contrast-Associated Nephropathy After Coronary Angiography
Completed	`NCT04225013` - Early Diagnosis as Strategy in Reducing the Incidence of Contrast-induced Nephropathy
Recruiting	`NCT02489240` - Efficacy Study of Vitamin D to Treat Contrast-induced Nephropathy	N/A